High-sensitivity C-reactive protein (hsCRP) has been demonstrated to play a causal role in atherosclerosis and to predict cardiovascular events in the general population. On the other hand, left ventricular (LV) hypertrophy and diastolic dysfunction assessed by echocardiography can also predict cardiovascular events in patients with cardiovascular risk factors. However, there are few data regarding the relationships among hsCRP, LV hypertrophy, and diastolic function. We examined the relationships among hsCRP, LV hypertrophy, and diastolic function in 185 patients (65 ± 11 years), who had no overt heart disease, but had cardiovascular risk factors, including hypertension, diabetes, and dyslipidemia. Echocardiography was performed to measure the left ventricular mass index (LVMI) as a parameter of LV hypertrophy. LV diastolic function was assessed by the ratio (E/A) of early (E) and late (A) diastolic transmitral flows, early diastolic mitral annular velocity (E´), and the ratio (E/E´) of E to E´using Doppler echocardiography. The hsCRP was correlated with LVMI (r = 0.228, p = 0.002), E´ (r = −0.276, p < 0.001), and E/E´ (r = 0.419, p < 0.001). The E/E´ as a parameter of LV diastolic function showed the closest correlation to hsCRP. These results indicate that elevated hsCRP reflects LV diastolic dysfunction rather than LV hypertrophy. We therefore suggest that hsCRP may be a marker of subclinical LV diastolic dysfunction in patients with cardiovascular risk factors.
It is well known that left ventricular (LV) hypertrophy detected via an increase in left ventricular mass predicts an increased risk of cardiovascular events in patients with essential hypertension (Levy et al. 1990; Verdecchia et al. 1998) . On the other hand, LV diastolic dysfunction detected via a decreased transmitral early-to-late flow velocity ratio (E/A ratio) is also known to be a marker for increased risk of cardiovascular events (Schillaci et al. 2002; Redfield et al. 2003) . Echocardiography, which can assess LV hypertrophy and diastolic dysfunction, is formally recommended as a fundamental tool for risk stratification in patients with cardiovascular risk factors, including hypertension. However, there are no data comparing the utility of LV hypertrophy and diastolic dysfunction as markers predicting an increased risk of cardiovascular events in hypertensive patients.
Recently, high-sensitivity C-reactive protein (hsCRP) has been demonstrated to predict cardiovascular events in the general population (Ridker et al. 2000; Olsen et al. 2008) . Various studies have found C-reactive protein (CRP) to play a causal role in atherosclerosis (Torzewski et al. 1998; Zwaka et al. 2001) , metabolic syndrome (Ridker et al. 2003) , coronary heart disease and ischemic heart failure (Kardys et al. 2006) . Thus, hsCRP has been well used recently as an interesting therapeutic target for the prevention of cardiovascular disease (Pepys et al. 2006) .
However, previous studies focused on the effects of CRP on atherosclerosis and ischemic heart disease (Memon et al. 2006; Eyileten et al. 2007 ). There are some data regarding the relationships between hsCRP and echocardiographic parameters, which can assess the risks of cardiovascular events in patients with cardiovascular risk factors, including hypertension, diabetes, and dyslipidemia (deFilippi et al. 2003; Conen et al. 2006) . However, consensus is still lacking regarding the relationships between hsCRP and LV diastolic function assessed by echocardiography. In this study, we investigated the relationship between hsCRP and echocardiographic parameters, including LV hypertrophy and diastolic dysfunction, in patients with cardiovascular risk factors, including hypertension, diabetes, and dyslipidemia.
Methods

Subjects and protocol
The study subjects were 185 consecutive patients (89 male, 96 female; mean age 65 ± 11 years, range 21-87 years) who were diagnosed as having cardiovascular risk factors at Kagawa University Hospital from April, 2008 through October, 2010. Cardiovascular risk factors included in this study were hypertension, diabetes mellitus, and dyslipidemia, which were respectively diagnosed according to the guidelines of the Japanese Society of Hypertension, the Japan Diabetes Society and the Japan Atherosclerosis Society. Patients with a history of heart failure or obvious heart disease were excluded. None of the subjects had a history of atherosclerotic cardiovascular disease or stroke. Blood pressure was determined using the conventional cuff method at the time when the echocardiographic examination was performed. Hypertension was defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure of ≥ 90 mmHg. Echocardiographic examinations were performed to assess cardiac structural changes and cardiac function. Blood sampling was performed in the morning after a 12-hour overnight fast. Plasma total cholesterol, triglyceride, high-density lipoprotein cholesterol (HDL-C), and HbA1c were measured by standard laboratory techniques. Plasma high-sensitivity C-reactive protein (hsCRP) level was measured using a latex particle-enhanced immunoassay with the nephelometry method. Relationships between echocardiographic parameters and various clinical characteristics, including blood pressure and laboratory data, were analyzed. This protocol was approved by the Ethics Committee of Kagawa University. Informed consent was obtained from all participants.
Echocardiographic examination
Two-dimensional echocardiography and M-mode echocardiography were performed using the Vivid Seven System (GE; Horten, Norway). We first measured the following left ventricular structural parameters by M-mode echocardiography: ventricular septal thickness (VS) at the chordae tendineae level; left ventricular end-diastolic dimension (LVDd) and left ventricular end-systolic dimension (LVDs) at the chordae tendineae level; left ventricular posterior wall (PW) thickness at the chordae tendineae level; the end-systolic dimension of the left atrium (LAD); and the dimension of the ascending aorta (AO). The left ventricular mass was calculated according to the American Society of Echocardiography convention (Wallerson and Devereux 1987) (Teichholz et al. 1976 ) and was used as the parameter of left ventricular systolic function. We next measured the parameters of LV diastolic function by recording the transmitral flow velocity using conventional Doppler echocardiography (Nishimura and Appleton 1996; Nishimura and Tajik 1997) . The transmitral flow velocity was recorded from the apical transducer position with the sample volume situated between the mitral leaflet tips. The peak velocity of early transmitral flow velocity (E velocity) and the peak velocity of late transmitral flow velocity (A velocity) were recorded, and the ratio of E to A (E/A ratio) was calculated.
Furthermore, pulsed-wave tissue Doppler echocardiography was performed by activating the tissue Doppler echocardiographic function in the same machine. Mitral annular velocities were recorded from the apical window. Sample volumes were located at the septal site of the mitral annulus. Peak early (E´) and late (A´) diastolic mitral annular velocities and the ratio of early to late peak velocities (E´/A´) were measured over 3 cardiac cycles, and the results were averaged (Sohn et al. 1997; Ommen et al. 2000; Nikitin and Witte 2004) . These parameters obtained from tissue Doppler echocardiography were also analyzed as parameters of LV diastolic function (Masugata et al. 2008 (Masugata et al. , 2010 . Furthermore, the ratio of E velocity to E´ velocity (E/E´) was calculated and was used as a parameter of LV diastolic dysfunction. E/E´ is increased by an elevated left atrial pressure, which is produced by LV diastolic dysfunction (Nagueh et al. 1997 ).
Statistical analysis
Data are expressed as means ± s.d. Statistical analysis was performed using the SPSS software package (SPSS, Chicago, IL, USA). Linear regression analysis was performed to evaluate the association between hsCRP and other variables.
Step-wise multiple regression analysis was performed to determine the correlation between hsCRP and each independent variable. Values of p < 0.05 were considered to indicate statistical significance.
Results
Clinical and echocardiographic characteristics of subjects
The clinical and echocardiographic parameters of the study subjects are summarized in Table 1 . The prevalence of hypertension was considerably high (82%), but the mean systolic blood pressure of all subjects was not particularly high because the blood pressure of hypertensive patients was well controlled by medication. The mean value of hsCRP was high because the participants included patients with hypertension or diabetes. The mean LVEF was 72 ± 7%; all patients had normal systolic function. The elevated mean LVMI indicated the presence of LV hypertrophy in the subjects overall. In addition, the decreased mean E/A and E´ indicated LV diastolic dysfunction, which was produced by hypertension or diabetes.
Association between hsCRP and other variables
Linear regression analysis was performed to examine the relationship between hsCRP and other variables in all subjects ( Table 2 ). The hsCRP was correlated with the presence of hypertension, the presence of diabetes, the number of cardiovascular risk factors, HbA1c, LVMI, E´, E´/A´, and E/E´. The E/E´ showed the closest correlation to hsCRP among the echocardiographic parameters (Fig. 1) .
Assessment of the factors related to hsCRP
Stepwise multiple regression analysis was performed to identify which clinical and echocardiographic parameters were independently associated with hsCRP. Stepwise multiple regression analysis was performed for the parameters in Table 1 . This analysis indicated that E/E' (β coefficient = 0.399, p < 0.001) and the presence of diabetes (β coefficient = 0.153, p = 0.032) were independently associated with hsCRP (Table 3) . Thus, among the echocardiographic parameters, only E/E' was independently associated with hsCRP.
Discussion
The present study presents data regarding the relationships between hsCRP and various echocardiographic parameters in patients with cardiovascular risk factors. The data led us to the following conclusions: (1) hsCRP is more closely related to LV diastolic function as assessed by E/E' than to LV hypertrophy as assessed by LVMI; and (2) E/E' and the presence of diabetes are independent determinants of hsCRP.
The most striking result in our analysis is that increased hsCRP may reflect LV diastolic dysfunction rather than LV hypertrophy in patients with cardiovascular risk factors. As our data demonstrated a significant correlation between hsCRP and E/E', increased hsCRP may be a marker of LV diastolic dysfunction. Previous studies (Anand et al. 2005; Ratnasamy et al. 2008 ) established a strong association between hsCRP and the severity of symptoms in patients with advanced heart failure. However, there are no data regarding the associations BMI, body mass index; RASB, renin-angiotensin system blockers; BP, blood pressure; HDL, high-density lipoprotein; hsCRP, high-sensitive C-reactive protein; LV, left ventricular; LVMI, left ventricular mass index; LVEF, left ventricular ejection fraction; LAD, left atrial dimension; AO, dimension of ascending aorta; E, peak early diastolic transmitral flow; A, peak late diastolic transmitral flow; E/A, the ratio of E to A; E´, peak early diastolic annular velocity; A´, peak late diastolic annular velocity; E´/A´, the ratio of E´ to A´; E/E´, the ratio of E to E´. between hsCRP and echocardiographic parameters in patients with cardiovascular risk factors but who do not show obvious heart failure. Careful prevention of heart failure is essential for patients with cardiovascular risk factors who do not show obvious heart failure, because hypertension and diabetes are the most important risk factors for heart failure with preserved LV ejection fraction (Judge et al. 1991) , which is, in other words, diastolic heart failure with preserved LV systolic function (Bonow and Udelson 1992) . Our data suggest that hsCRP may be clinically useful for detecting subclinical LV diastolic dysfunction in patients with cardiovascular risk factors.
The association between hsCRP and LV diastolic dysfunction in the present study may be attributed to the high prevalence of hypertension (82%) and diabetes (31%) in the participants. In the present study, hsCRP is associated with the presence of hypertension ( p = 0.008) and diabetes ( p = 0.006) ( Table 2) , and the presence of diabetes was an independent determinant of hsCRP (Table 3) . Previous studies demonstrated the association between hsCRP and microvascular complications, including nephropathy and retinopathy, in patients with hypertension (Shantha et al. 2010 ) and diabetes (Kang et al. 2004; Kajitani et al. 2010) . Because LV diastolic dysfunction is also produced by microvascular complication in hypertension (Hoenig et al. 2008 ) and diabetes (Brooks et al. 2008) , LV diastolic dysfunction is likely to be associated with increased hsCRP.
Some previous animal studies demonstrated that angiotensin II triggered the inflammatory response and played a key role in reactive myocardial fibrosis and LV diastolic dysfunction in hypertensive hearts (Kuwahara et al. 2002 (Kuwahara et al. , 2004 . A recent clinical study (Futai et al. 2009) reported that an angiotensin II receptor blocker, which is one of the renin-angiotensin system blockers (RASBs), improved LV diastolic dysfunction and decreased hsCRP in hypertensive patients. In the present study, hsCRP did not differ between patients (0.22 ± 0.26 mg/dL) with RASBs and those (0.21 ± 0.28 mg/dL) without RASBs. However, the present study was a cross-sectional study. A follow-up study may be needed to determine the effects of ARBs on LV diastolic function and hsCRP. The present study has several limitations. First, we performed the E/E´ analysis based on E/E´ at the septal mitral annulus. The increased mean E/E´ (11.6 ± 3.8) of the present study suggested an increase in left atrial pressure, which was produced by LV diastolic dysfunction (Nagueh et al. 1997) . However, several studies (Kasner et al. 2007; Paulus et al. 2007) recommended that E/E´ analysis should be performed by measuring the velocities of the lateral mitral annulus or calculating averaged velocities of lateral and septal mitral annulus to detect diastolic dysfunction. Further studies are needed to examine the influences of different locations of mitral annular velocity measurement. Second, we had no data regarding insulin resistance and atherosclerosis in the present study. Insulin resistance and atherosclerosis (microvascular complications) share a com- Fig. 1 . Relationships among hsCRP, E´, and E/E´.
The hsCRP was correlated with E´ and E/E´, which were parameters of LV diastolic function. The E/E' showed the closest correlation to hsCRP among the echocardiographic parameters. hsCRP, high-sensitive C-reactive protein; E, peak early diastolic transmitral flow; E´, peak early diastolic annular velocity; E/E', the ratio of E to E´. Abbreviations the same as in Table 1. mon inflammatory basis. Further studies are needed to examine the relationships between insulin resistance, microvascular complications, and LV diastolic dysfunction in patients with cardiovascular risk factors.
In conclusion, hsCRP is more closely related to LV diastolic dysfunction as assessed by E/E' than to LV hypertrophy as assessed by LVMI. This finding raises the possibility that hsCRP may be a marker of subclinical LV diastolic dysfunction in patients with cardiovascular risk factors, including hypertension and diabetes.
